Global Erectile Dysfunction Market Growth 2025-2031

Global Erectile Dysfunction Market Growth 2025-2031

The global Erectile Dysfunction market size is predicted to grow from US$ 6202 million in 2025 to US$ 9467 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

The erectile dysfunction (ED) drug market is experiencing significant growth. The main drivers of market growth include the increase in the elderly population, increased awareness of ED, innovation in treatment methods, and favorable reimbursement policies.

The prevalence of ED is rising globally, with an estimated 15% of men affected by ED each year and expected to affect 320 million people by 2025. The incidence of ED increases with age, and the growth of the elderly population is one of the key factors driving the growth of the ED drugs market.

Technological advancements such as new drug development, innovations in drug delivery systems such as sublingual tablets, topical creams, and nasal sprays are also driving market growth. Additionally, the rise of telemedicine services is changing how ED treatment is obtained.

The market is highly concentrated, with major players including Bayer, Eli Lilly, Pfizer, Teva and other companies. These companies strengthen their market positions by launching new drugs, expanding product portfolios and market coverage.

In terms of products, sildenafil (Viagra) held the largest market share in 2023, followed by tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra).

In terms of route of administration, oral drugs accounted for the largest market share in 2023, and other routes, including topical and intraurethral delivery, are expected to grow at the fastest rate.

From a regional perspective, North America is the largest market, accounting for more than 40% of the market share, followed by Asia Pacific and Europe.

Overall, the ED drugs market is driven by several factors, including increasing geriatric population, changing lifestyles, technological advancements, and rising awareness about ED treatments. The market is expected to continue to expand as new drugs and new treatment modalities are developed.

LP Information, Inc. (LPI) ' newest research report, the “Erectile Dysfunction Industry Forecast” looks at past sales and reviews total world Erectile Dysfunction sales in 2024, providing a comprehensive analysis by region and market sector of projected Erectile Dysfunction sales for 2025 through 2031. With Erectile Dysfunction sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erectile Dysfunction industry.

This Insight Report provides a comprehensive analysis of the global Erectile Dysfunction landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erectile Dysfunction portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Erectile Dysfunction market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erectile Dysfunction and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erectile Dysfunction.

This report presents a comprehensive overview, market shares, and growth opportunities of Erectile Dysfunction market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Sildenafil
Tadalafil
Others

Segmentation by Application:
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy

Key Questions Addressed in this Report

What is the 10-year outlook for the global Erectile Dysfunction market?

What factors are driving Erectile Dysfunction market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Erectile Dysfunction market opportunities vary by end market size?

How does Erectile Dysfunction break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.